Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Colonic Neoplasms × HuMax-IL8 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasms 1 Melanoma 1 Hematologic Neoplasms 1 Coronavirus Infections 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 COVID-19 1

Interventions

Oxaliplatin 107 Fluorouracil 97 Leucovorin 85 Irinotecan 82 Capecitabine 53 Bevacizumab 52 Cetuximab 40 Folfox protocol 27 Colonoscopy 21 Blood Specimen Collection 19 Chemotherapy, Adjuvant 18 Panitumumab 17 Nivolumab 16 Drug Therapy 16 Exercise 15 Radiotherapy 14 Surveys and Questionnaires 13 Laparoscopy 13 Floxuridine 13 Early Intervention, Educational 13 XELOX 12 Magnetic Resonance Spectroscopy 12 trifluridine tipiracil drug combination 11 pembrolizumab 11 Surgical Procedures, Operative 11 Immunohistochemistry 11 Methods 10 Colectomy 10 Aspirin 10 Propofol 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03026140 2026-03-05

NICHE

The Netherlands Cancer Institute

Phase 2 Recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡